ロード中...
Cardiovascular disease risk factors among transgender women in Chiang Mai, Thailand
Transgender individuals take hormone therapy (HT) for transitioning secondary sexual characteristics, especially by transgender women assigned male at birth (AMAB). The transgender drug is a relatively new field in health care, but limited data exist to inform the cardiovascular risk factor profile...
保存先:
| 出版年: | Am J Cardiovasc Dis |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
e-Century Publishing Corporation
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7364281/ https://ncbi.nlm.nih.gov/pubmed/32685270 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|